BCM
ARGX icon

BlueCrest Capital Management’s argenx ARGX Stock Holding History

BlueCrest Capital Management’s Portfolio ARGX Stock Details ARGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-6,005
Closed -$455K – 864
2018
Q3 		$455K Buy
+6,005
New +$532K 0.01% 801

Other funds holding ARGX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlueCrest Capital Management's ARGX Position: Q4 2018 in Review

BlueCrest Capital Management sold out of argenx (ARGX) in Q4 2018, closing a stake of 6,005 shares — an estimated $455K sold.

BlueCrest Capital Management first reported a position in ARGX in Q3 2018 and held it in 1 quarter. The position peaked at $455K in Q3 2018. 110 funds tracked by Wall St. Rank hold ARGX as of Q4 2018.

  • BlueCrest Capital Management reported no remaining argenx position as of Q4 2018 after selling out during the quarter.
  • BlueCrest Capital Management sold 6,005 argenx shares in Q4 2018, an estimated $455K.
  • BlueCrest Capital Management first reported a position in argenx in Q3 2018 and held it in 1 quarter.
  • BlueCrest Capital Management's argenx position peaked at $455K in Q3 2018.
  • 110 funds tracked by Wall St. Rank held argenx as of Q4 2018.

Based on BlueCrest Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.